Targeted Therapy for Liver Cancer Assisted by Nanotechnology | Taeghwan Hyeon | TEDxKFAS
Due to the limited effect of existing drugs, liver cancer has one of the worst prognoses for survival, and being diagnosed with it is essentially a death sentence. Nanoparticle synthesis expert Dr. Taeghwan Hyeon explains that by using the nanoparticle form of triptolide with a grenade and missile function, we can treat liver cancer more effectively.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community.
Learn more at http://tedxkfas.com
Dr. Taeghwan Hyeon is Professor/SNU Distinguished Fellow at the Chemical and Biological Engineering of Seoul National University (SNU), and also Director of Center for Nanoparticle Research of Institute for Basic Science (IBS). For the last 17 years, he has been working on the synthesis and medical applications of uniform-sized nanoparticles at SNU, and was selected as one of the top 100 chemists by UNESCO&IUPAC in 2011. Since 2010, he has served as an Associate Editor of Journal of the American Chemical Society. He is a Fellow of the Royal Society of Chemistry (RSC) and the Materials Research Society (MRS). He received many awards including the Hoam Prize (2012, Samsung Hoam Foundation) and the POSCO-T. J. Park Award (2008).
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
-
Category
No comments found